Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 334 citing Bostom: Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons:.... (0.13 sec) 

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

- idpas.org [PDF] 
S Seshadri, A Beiser, J Selhub, PF Jacques, … - New England Journal of Medicine, 2002 - content.nejm.org
476 · N Engl J Med, Vol. 346, No. 7 · February 14, 2002 · www.nejm.org ...
PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR DEMENTIA AND ALZHEIMER'S DISEASE ... S
UDHA S ESHADRI , MD, A LEXA B EISER , P H .D., J ACOB S ELHUB , P H .D., P ...
Cited by 1278 - Related articles - BL Direct - All 13 versions

Primary prevention of ischemic stroke: a statement for healthcare professionals from the …


LB Goldstein, R Adams, K Becker, CD Furberg … - Circulation, 2001 - Am Heart Assoc
As given in Tables 2 through 4 Down Down Down , risk factors or risk markers for
a first stroke were classified according to potential for modification
(nonmodifiable, modifiable, or potentially modifiable) and strength of ...
Cited by 762 - Related articles - BL Direct - All 13 versions

The controversy over homocysteine and cardiovascular risk

- ajcn.org
PM Ueland, H Refsum, SAA Beresford, SE … - American journal of clinical nutrition, 2000 - Am Soc Nutrition
Elevated plasma total homocysteine (tHcy) is a risk factor for occlusive
cardiovascular disease (CVD). This concept is based on the observations of
premature vascular disease in patients with homocystinuria, the relation ...
Cited by 387 - Related articles - BL Direct - All 8 versions

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in …

- nih.gov
MA Hofmann, E Lalla, Y Lu, MR Gleason, BM … - Journal of Clinical Investigation, 2001 - Am Soc Clin Investig
Although hyperhomocysteinemia (HHcy) is a well-known risk factor for the
development of cardiovascular disease, the underlying molecular mechanisms are
not fully elucidated. Here we show that induction of HHcy in apoE-null mice ...
Cited by 338 - Related articles - BL Direct - All 11 versions

Recommendations for the outpatient surveillance of renal transplant recipients

- asnjournals.org
BL Kasiske, MA Vazquez, WE Harmon, RS … - Journal of the American Society of Nephrology, 2000 - Am Soc Nephrol
Abstract. Many complications after renal transplantation can be prevented if
they are detected early. Guidelines have been developed for the prevention of
diseases in the general population, but there are no comprehensive ...
Cited by 336 - Related articles - BL Direct - All 8 versions

Homocyst (e) ine and cardiovascular disease: a systematic review of the evidence with …

- oxfordjournals.org
ES Ford, SJ Smith, DF Stroup, KK Steinberg, … - International journal of epidemiology, 2002 - IEA
E Ford, Division of Nutrition and Physical Activity, National Center for Chronic
Disease Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Highway, MS K24, Atlanta, GA 30341, USA.
Cited by 192 - Related articles - BL Direct - All 8 versions

Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke …


PB Gorelick - Stroke, 2002 - Am Heart Assoc
Background— It is estimated that about half of cardiovascular disease risk is
explained by conventional risk factors. The realization that atherosclerosis is
an inflammatory disease has led to a search for new stroke and ...
Cited by 195 - Related articles - BL Direct - All 9 versions

Homocysteine, MTHFR 677C-> T polymorphism, and risk of ischemic stroke: results of a …


PJ Kelly, J Rosand, JP Kistler, VE Shih, S … - Neurology, 2002 - AAN Enterprises
Methods: Search of MEDLINE, Science Citation Index, and abstracts of conference
proceedings revealed relevant articles. Exposure was defined as follows: 1)
prevalence of hyper-Hcy; 2) absolute difference in the mean Hcy ...
Cited by 180 - Related articles - BL Direct - All 6 versions

Homocysteine and Methylmalonic Acid: Markers to Predict and Avoid Toxicity from …


C Niyikiza, SD Baker, DE Seitz, JM Walling, K … - Molecular Cancer Therapeutics, 2002 - AACR
The purpose of this study was to identify predictive factors for severe toxicity
caused by antifolate-chemotherapy using pemetrexed (ALIMTA, LY231514), as a
model. Data on potential predictive factors for severe toxicity from ...
Cited by 165 - Related articles - All 6 versions

Homocysteine and cardiovascular disease: current evidence and future prospects


AA Mangoni, SHD Jackson - The American journal of medicine, 2002 - Elsevier
Because only about two thirds of cardiovascular events are related to
well-established genetic and environmental risk factors, there is an ongoing
search for new markers of cardiovascular risk [1]. Hyperhomocysteinemia is ...
Cited by 164 - Related articles - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google